Diagnostic products and services in the US had been witnessing a strong demand over the past few years, backed by favorable reimbursement policies for clinical lab testing, increasing awareness about early disease detection, and ever increasing aging population.
The US diagnostic market accounts majorly in the total healthcare market. The market is anticipated to sustain its growth pace in the coming years also, which will attract investors across the world.
According to our research report, "US Diagnostic Market Outlook 2014", the US represents world’s largest and one of the most developed diagnostic markets. Huge investment in research and developments and commercially successful technological innovations in diagnostic industry is facilitating the US to outperform other prominent diagnostic markets including EU, Japan, and many other countries, etc. Looking ahead, the US is expected to maintain its lead position as the world’s highest IVD products demand, growing at a moderate CAGR of around 9% during 2010-2014.
Our segment-level analysis showed that clinical chemistry is grabbing the biggest market share of the total IVD products demand. Although the segment’s future growth is expected to witness a slow growth, yet it is likely to sustain its topmost position in the market by 2014. Considering the growth rates, the demand for molecular diagnostic IVD products is anticipated to outpace all the other segments, owing to selectivity, sensitivity, speed, accuracy, and breadth of application advantages over alternative IVDs.
Our report, "US Diagnostic Market Outlook 2014" has been authored to evaluate the US diagnostic market potentials and identify future growth opportunities. It provides extensive research and analysis on current market trends and future forecasts on all prominent diagnostic techniques including clinical chemistry, immunoassays, blood testing, and molecular diagnostic.
The report also provides an insight into the competitive landscape of both diagnostics and lab services market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the fast growing US diagnostic market.
The US diagnostic market accounts majorly in the total healthcare market. The market is anticipated to sustain its growth pace in the coming years also, which will attract investors across the world.
According to our research report, "US Diagnostic Market Outlook 2014", the US represents world’s largest and one of the most developed diagnostic markets. Huge investment in research and developments and commercially successful technological innovations in diagnostic industry is facilitating the US to outperform other prominent diagnostic markets including EU, Japan, and many other countries, etc. Looking ahead, the US is expected to maintain its lead position as the world’s highest IVD products demand, growing at a moderate CAGR of around 9% during 2010-2014.
Our segment-level analysis showed that clinical chemistry is grabbing the biggest market share of the total IVD products demand. Although the segment’s future growth is expected to witness a slow growth, yet it is likely to sustain its topmost position in the market by 2014. Considering the growth rates, the demand for molecular diagnostic IVD products is anticipated to outpace all the other segments, owing to selectivity, sensitivity, speed, accuracy, and breadth of application advantages over alternative IVDs.
Our report, "US Diagnostic Market Outlook 2014" has been authored to evaluate the US diagnostic market potentials and identify future growth opportunities. It provides extensive research and analysis on current market trends and future forecasts on all prominent diagnostic techniques including clinical chemistry, immunoassays, blood testing, and molecular diagnostic.
The report also provides an insight into the competitive landscape of both diagnostics and lab services market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the fast growing US diagnostic market.
- 1. Analyst View
- 2. Research Methodology
- 3. Emerging Market Trends and Drivers
- 3.1 Diagnostics: Heading towards Diversified Applications
- 3.2 Cancer Diagnostics: Key Focus Area for Industry Players
- 3.3 Patient Monitoring: Benefiting from Diagnostic Advancements
- 3.4 Improving Life Expectancy: Stimulating Diagnostic Market
- 4. Industry Overview
- 4.1 Medical Imaging Equipments
- 4.2 IVD Products
- 4.2.1 Clinical Chemistry
- 4.2.2 Molecular Diagnostic
- 4.2.3 Blood Testing
- 4.2.4 Immunoassay
- 4.3 Segmentation by Indication
- 4.3.1 Diabetes
- 4.3.2 Cardiovascular
- 4.3.3 Cancer
- 4.3.4 HIV
- 5. Clinical Lab Services Market
- 6. Competitive Landscape
- 6.1 By Diagnostic Products
- 6.1.1 Roche Holding Ltd
- 6.1.2 Johnson & Johnson
- 6.1.3 BioMérieux S.A.
- 6.1.4 Siemens AG
- 6.1.5 Becton, Dickinson and Company
- 6.1.6 Abbott Laboratories
- 6.1.7 Beckman Coulter, Inc
- 6.1.8 Gen-Probe Inc.
- 6.2 By Services
- 6.2.1 Quest Diagnostics Inc.
- 6.2.2 Laboratory Corporation of America Holdings
- 6.2.3 Genomic Health Inc.
- List of Figures:
- Figure 3-1: Patient Monitoring System Demand (Billion US$), 2010-2014
- Figure 4-1: Medical Imaging Equipment Demand (Billion US$), 2010-2014
- Figure 4-2: IVD Products Demand (Billion US$), 2010-2014
- Figure 4-3: IVD Products Demand by Clinical Segment (%), 2010 & 2014
- Figure 4-4: Clinical Chemistry Products Demand (Billion US$), 2010-2014
- Figure 4-5: Molecular Diagnostic Products Demand (Billion US$), 2010-2014
- Figure 4-6: Blood Testing Products Demand (Billion US$), 2010-2014
- Figure 4-7: Immunoassay Products Demand (Billion US$), 2010-2014
- Figure 4-8: Number of Diabetic Population (Million), 2010 & 2030
- Figure 4-9: Blood Glucose Monitoring Market (Billion US$), 2010-2014
- Figure 4-10: Cardiovascular Diagnostics Market (Billion US$), 2010-2014
- Figure 4-11: Cancer Diagnostics Market (Billion US$), 2010-2014
- Figure 5-1: Breakup of Clinical Labs by Type (%), 2010
- Figure 5-2: Clinical Lab Services Market (Billion US$), 2010-2014
- List of Tables:
- Table 3-1: Life Expectancy and Prevalence of Diseases by Countries
- Table 4-1: List of HIV Diagnostic Products
- Table 6-1: Roche Holding Ltd - Strengths & Weaknesses
- Table 6-2: Johnson & Johnson- Strengths & Weaknesses
- Table 6-3: BioMérieux S.A. - Strengths & Weaknesses
- Table 6-4: Siemens AG - Strengths & Weaknesses
- Table 6-5: Becton, Dickinson and Company - Strengths & Weaknesses
- Table 6-6: Abbott Laboratories - Strengths & Weaknesses
- Table 6-7: Beckman Coulter, Inc - Strengths & Weaknesses
- Table 6-8: Gen-Probe Inc. - Strengths & Weaknesses
- Table 6-9: Quest Diagnostics Inc. - Strengths & Weaknesses
- Table 6-10: Laboratory Corporation of America Holdings - Strengths & Weaknesses
- Table 6-11: Genomic Health Inc. - Strengths & Weaknesses
Other selected research from the 'USA' category:
US Healthcare Sector Forecast to 2012
The US represents the world’s largest healthcare market, with an annual spending of around US$ 2.34 Trillion in 2008. Growth in annual spending was mainly driven by increasing use... Learn More
OTC Pharmaceuticals - North America (NAFTA) Industry Guide
Datamonitor’s OTC Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the North American Free... Learn More
Other selected research from the 'Diagnostics' category:
Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets
This report analyzes the current and potential world market for medical MRI andultrasound systems. This report generally reviews the nature and direction of research, aswell as future markets for two... Learn More
Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016SummaryGlobalData’s new report, “Mammography Equipment - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key... Learn More
